1. Home
  2. About FDA
  3. Reports, Manuals, & Forms
  4. Reports
  5. Economic Impact Analyses of FDA Regulations
  6. Revocation of Regulations Regarding the Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device
  1. Economic Impact Analyses of FDA Regulations

Revocation of Regulations Regarding the Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device

The Food and Drug Administration is issuing a final rule revoking the regulations entitled ‘‘Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and The European Community.’’ FDA is taking this action because the regulations at 21 CFR part 26 have been superseded in part by the ‘‘United States-European Union Amended Sectoral Annex for Pharmaceutical Good Manufacturing Practices (GMPs)’’ that entered into force in 2017 (2017 Amended Pharmaceutical Annex), are outdated, do not reflect current Agency practice, and are unnecessary. The full text of the final rule, including the Regulatory Impact Analysis, can be viewed at:
https://www.federalregister.gov/documents/2026/02/19/2026-03286/revocation-of-regulations-regarding-the-mutual-recognition-of-pharmaceutical-good-manufacturing

Federal Register: 91 FR 7825 
Publication Date: 02/19/2026 
Docket: FDA-2024-N-4016

Back to Top